Ute Hennrich

6PUBLICATIONS
3CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Radiation therapyPharmacogenomicsDental materials and equipmentPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 27, 2025
Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.

Ute Hennrich, Laurène Wagner, Harun Taş

|Oct 27, 2022
[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer.

Ute Hennrich, Matthias Eder

|Aug 28, 2021
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer.

Ute Hennrich, Matthias Eder

|Mar 06, 2021
Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [18F]PSMA-1007, a PET Tracer for the Imaging of Prostate Cancer.

Ines Katzschmann, Heike Marx, Klaus Kopka

|Mar 07, 2020
[68Ga]Ga-DOTA-TOC: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging.

Ute Hennrich, Martina Benešová

|Aug 01, 2019
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy.

Ute Hennrich, Klaus Kopka

Pageof 1

Frequent Collaborators

1 joint publications

Klaus Kopka

1 joint publications

Laurène Wagner

1 joint publications

Harun Taş